These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 7648666)

  • 1. Morning peak in ventricular tachyarrhythmias detected by time of implantable cardioverter/defibrillator therapy. The CPI Investigators.
    Tofler GH; Gebara OC; Mittleman MA; Taylor P; Siegel W; Venditti FJ; Rasmussen CA; Muller JE
    Circulation; 1995 Sep; 92(5):1203-8. PubMed ID: 7648666
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Implantable cardioverter-defibrillator therapy: influence of left ventricular function on long-term results.
    Pitschner HF; Neuzner J; Himmrich E; Liebrich A; Jung J; Heisel A
    J Interv Card Electrophysiol; 1997 Nov; 1(3):211-20. PubMed ID: 9869974
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circadian variations of ventricular tachyarrhythmias detected by the implantable cardioverter-defibrillator.
    Auricchio A; Klein H
    G Ital Cardiol; 1997 Feb; 27(2):113-22. PubMed ID: 9199946
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circadian variation of sustained ventricular tachyarrhythmias terminated by appropriate shocks in patients with an implantable cardioverter defibrillator.
    Behrens S; Galecka M; Brüggemann T; Ehlers C; Willich SN; Ziss W; Dissmann R; Andresen D
    Am Heart J; 1995 Jul; 130(1):79-84. PubMed ID: 7611127
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modification of the circadian pattern of ventricular tachyarrhythmias by beta-blocker therapy.
    Behrens S; Ehlers C; Brüggemann T; Ziss W; Dissmann R; Galecka M; Willich SN; Andresen D
    Clin Cardiol; 1997 Mar; 20(3):253-7. PubMed ID: 9068912
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circadian variation of sustained ventricular tachycardia in patients with coronary artery disease and implantable cardioverter-defibrillators.
    Lampert R; Rosenfeld L; Batsford W; Lee F; McPherson C
    Circulation; 1994 Jul; 90(1):241-7. PubMed ID: 8026004
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Diurnal distribution of spontaneous ventricular tachyarrhythmias in patients with implanted cardioverter defibrillator].
    Fries R; Heisel A; Jung J; Stopp M; Schieffer H; Ozbek C
    Z Kardiol; 1996 Feb; 85(2):140-7. PubMed ID: 8650984
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reversed circadian rhythms of heart rate variability and morning peak occurrence of sustained ventricular tachyarrhythmias in patients with implanted cardioverter defibrillator.
    Sezgin A; Demircan S; Yalcin F
    Med Sci Monit; 2003 Feb; 9(2):LE1; author reply LE2. PubMed ID: 12643268
    [No Abstract]   [Full Text] [Related]  

  • 9. Reversed circadian rhythms of heart rate variability and morning peak occurrence of sustained ventricular tachyarrhythmias in patients with implanted cardioverter defibrillator.
    Fries R; Hein S; K nig J
    Med Sci Monit; 2002 Nov; 8(11):CR751-6. PubMed ID: 12444379
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circadian and seasonal variations of ventricular tachyarrhythmias in patients with early repolarization syndrome and Brugada syndrome: analysis of patients with implantable cardioverter defibrillator.
    Kim SH; Nam GB; Baek S; Choi HO; Kim KH; Choi KJ; Joung B; Pak HN; Lee MH; Kim SS; Park SJ; On YK; Kim JS; Oh IY; Choi EK; Oh S; Choi YS; Choi JI; Park SW; Kim YH; Lee MY; Lim HE; Lee YS; Cho Y; Kim J; Lee DI; Cho DK; Kim YH
    J Cardiovasc Electrophysiol; 2012 Jul; 23(7):757-63. PubMed ID: 22353358
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unexpected deviation in circadian variation of ventricular arrhythmias: the SCD-HeFT (Sudden Cardiac Death in Heart Failure Trial).
    Patton KK; Hellkamp AS; Lee KL; Mark DB; Johnson GW; Anderson J; Bardy GH; Poole JE;
    J Am Coll Cardiol; 2014 Jun; 63(24):2702-8. PubMed ID: 24747100
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term outcome of implantable cardioverter-defibrillator implantation in secondary prevention of sudden cardiac death.
    Boulé S; Sémichon M; Guédon-Moreau L; Drumez É; Kouakam C; Marquié C; Brigadeau F; Kacet S; Potelle C; Escande W; Souissi Z; Lacroix D; Duhamel A; Klug D
    Arch Cardiovasc Dis; 2016 Oct; 109(10):517-526. PubMed ID: 27342808
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Strain echocardiography improves risk prediction of ventricular arrhythmias after myocardial infarction.
    Haugaa KH; Grenne BL; Eek CH; Ersbøll M; Valeur N; Svendsen JH; Florian A; Sjøli B; Brunvand H; Køber L; Voigt JU; Desmet W; Smiseth OA; Edvardsen T
    JACC Cardiovasc Imaging; 2013 Aug; 6(8):841-50. PubMed ID: 23850251
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Do patients with an implantable defibrillator live longer?
    Böcker D; Block M; Isbruch F; Wietholt D; Hammel D; Borggrefe M; Breithardt G
    J Am Coll Cardiol; 1993 Jun; 21(7):1638-44. PubMed ID: 8496531
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of the wearable cardioverter defibrillator in high-risk cardiac patients: data from the Prospective Registry of Patients Using the Wearable Cardioverter Defibrillator (WEARIT-II Registry).
    Kutyifa V; Moss AJ; Klein H; Biton Y; McNitt S; MacKecknie B; Zareba W; Goldenberg I
    Circulation; 2015 Oct; 132(17):1613-9. PubMed ID: 26316618
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circadian patterns in the occurrence of malignant ventricular tachyarrhythmias triggering defibrillator interventions in patients with hypertrophic cardiomyopathy.
    Maron BJ; Semsarian C; Shen WK; Link MS; Epstein AE; Estes NA; Almquist A; Giudici MC; Haas TS; Hodges JS; Spirito P
    Heart Rhythm; 2009 May; 6(5):599-602. PubMed ID: 19332391
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The implantable cardioverter/defibrillator].
    Kuck KH; Siebels J; Schlüter M; Meinertz T
    Herz; 1994 Oct; 19(5):287-93. PubMed ID: 8001901
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dofetilide reduces the frequency of ventricular arrhythmias and implantable cardioverter defibrillator therapies.
    Baquero GA; Banchs JE; Depalma S; Young SK; Penny-Peterson ED; Samii SM; Wolbrette DL; Naccarelli GV; Gonzalez MD
    J Cardiovasc Electrophysiol; 2012 Mar; 23(3):296-301. PubMed ID: 21955243
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced detection criteria in implantable cardioverter defibrillators: sensitivity and specificity of the stability algorithm at different heart rates.
    Kettering K; Dörnberger V; Lang R; Vonthein R; Suchalla R; Bosch RF; Mewis C; Eigenberger B; Kühlkamp V
    Pacing Clin Electrophysiol; 2001 Sep; 24(9 Pt 1):1325-33. PubMed ID: 11584454
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circadian variations in the occurrence of ventricular tachyarrhythmias in patients with implantable cardioverter defibrillators.
    Kozák M; Krivan L; Semrád B
    Pacing Clin Electrophysiol; 2003 Mar; 26(3):731-5. PubMed ID: 12698674
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.